J&J Q3 Earnings Beat Estimates, Sales Miss, View Raised, Stock Down

EarningsNeutral

AI Analysis

Summary

Johnson & Johnson reported Q3 earnings that beat EPS estimates while sales missed expectations. The company raised its full-year guidance despite the revenue shortfall and stock trading lower on the results.

Financial Highlights

EPS

beat estimates

Guidance

raised

Importance:6/10

Sentiment:

-0.20

earningsQ3revenue_misseps_beatguidance_raised

Related Companies

$JNJ

Read the original article

Published by yahoo_finance on October 13, 2026 1:57 PM

Read Original